Medicare Enrolled
Dr. Mazhar Elamir
Pulmonary Disease · Jersey City, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Elamir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Elamir?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Elamir
Dr. Mazhar Elamir is a pulmonary disease specialist in Jersey City, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Elamir performed 4,798 Medicare services across 1,862 unique beneficiaries.
Between the years covered by Open Payments, Dr. Elamir received a total of $117,086 from 77 pharmaceutical and/or device companies across 723 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Elamir is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in NJ
$117,086 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,798
Medicare services
Top 5% in NJ for pulmonary disease
1,862
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~253 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,161 | $70 | $108 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
792 | $28 | $67 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
754 | $43 | $68 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $111 | $157 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
270 | $12 | $17 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
216 | $93 | $173 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
214 | $113 | $155 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
183 | $0 | $5 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
150 | $71 | $120 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
138 | $66 | $127 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
49 | $0 | $196 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
47 | $12 | $23 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
47 | $34 | $60 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
45 | $35 | $79 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
45 | $1 | $7 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
36 | $142 | $150 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
33 | $48 | $100 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
29 | $33 | $50 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
29 | $117 | $250 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $80 | $138 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
24 | $34 | $44 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
24 | $50 | $62 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
19 | $60 | $91 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
19 | $52 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$117,086
Total received (2018-2024)
Avg $16,727/year across 7 years
Top 2% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
723
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$108,334 (92.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,752 (7.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,853
2023
$26,409
2022
$16,837
2021
$19,658
2020
$35,896
2019
$1,339
2018
$2,093
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$13,956
Gilead Sciences, Inc.
$181
AstraZeneca Pharmaceuticals LP
$161
Lilly USA, LLC
$133
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$101
ANI Pharmaceuticals, Inc.
$64
Electromed, Inc.
$63
Avadel CNS Pharmaceuticals, LLC
$38
United Therapeutics Corporation
$34
Amgen Inc.
$34
Inspire Medical Systems, Inc.
$31
Novo Nordisk Inc
$17
ABBVIE INC.
$15
Intra-Sana Laboratories
$14
Athena Bioscience, LLC
$10
Top 3 companies account for 96.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$108,756
PFIZER INC.
$734
AstraZeneca Pharmaceuticals LP
$668
Lilly USA, LLC
$554
Novo Nordisk Inc
$534
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$430
Merck Sharp & Dohme Corporation
$402
SANOFI-AVENTIS U.S. LLC
$377
Gilead Sciences, Inc.
$310
Genentech USA, Inc.
$225
Mannkind Corporation
$220
Novartis Pharmaceuticals Corporation
$187
Amgen Inc.
$179
Merck Sharp & Dohme LLC
$170
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
Sunovion Pharmaceuticals Inc.
$148
Electromed, Inc.
$145
Allergan, Inc.
$141
Philips Electronics North America Corporation
$137
Regeneron Healthcare Solutions, Inc.
$134
Bayer HealthCare Pharmaceuticals Inc.
$123
MannKind Corporation
$119
GENZYME CORPORATION
$111
ANI Pharmaceuticals, Inc.
$109
Teva Pharmaceuticals USA, Inc.
$101
Amarin Pharma Inc.
$99
Bausch Health US, LLC
$84
Mylan Specialty L.P.
$83
Janssen Pharmaceuticals, Inc
$81
United Therapeutics Corporation
$77
ABBVIE INC.
$71
Hikma Pharmaceuticals USA
$64
DEXCOM, INC.
$62
Becton, Dickinson and Company
$58
AbbVie Inc.
$58
JAZZ PHARMACEUTICALS INC.
$57
Astellas Pharma US Inc
$55
Ferring Pharmaceuticals Inc.
$55
Dexcom, Inc.
$55
BIOTRONIK INC.
$55
Mallinckrodt Hospital Products Inc.
$50
ITI, Inc.
$47
Mallinckrodt Enterprises LLC
$41
DePuy Synthes Sales Inc.
$38
Forte Bio-Pharma LLC
$38
Nabriva Therapeutics, plc
$38
Avadel CNS Pharmaceuticals, LLC
$38
Boston Scientific Corporation
$37
Takeda Pharmaceuticals U.S.A., Inc.
$36
Xeris Pharmaceuticals, Inc.
$33
Actelion Pharmaceuticals US, Inc.
$31
Inspire Medical Systems, Inc.
$31
Allergan Inc.
$30
HARMONY BIOSCIENCES LLC
$29
E.R. Squibb & Sons, L.L.C.
$29
ALK-Abello, Inc
$27
Ironwood Pharmaceuticals, Inc
$27
Sumitomo Pharma America, Inc.
$24
Edwards Lifesciences Corporation
$19
Abbott Laboratories
$18
Nevro Corp.
$17
Exeltis, USA Inc.
$16
Baxter Healthcare
$16
Avanir Pharmaceuticals, Inc.
$15
Insmed, Inc.
$15
Mallinckrodt LLC
$15
Kowa Pharmaceuticals America, Inc.
$15
BioCryst US Sales Co., LLC
$15
Intra-Sana Laboratories
$14
Aytu BioScience, Inc
$14
Neurelis, Inc.
$14
Medicure Pharma Inc.
$14
LifeScan, Inc.
$13
Coloplast Corp
$13
Horizon Therapeutics plc
$13
Nestle HealthCare Nutrition Inc.
$12
Athena Bioscience, LLC
$10
Top 3 companies account for 94.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AFREZZA · AJOVY · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · Aimovig · AirDuo Digihaler · Amitiza · Arikayce · BASAGLAR · BD Nano · BD ULTRA-FINE · BD Ultra-Fine · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BRILINTA · BYSTOLIC · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CREON · DEXCOM G6 TRANSMITTER · DUEXIS · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUFLEXXA · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Esbriet · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · Hillrom - Life 2000 Ventilation System · INSPIRE · JANUVIA · JARDIANCE · Kerendia · Kloxxado · LINZESS · LOKELMA · LONHALA MAGNAIR · LUMRYZ · LYRICA · Livalo · MIGRANAL · MONOVISC · MOUNJARO · MYRBETRIQ · Mitigare · NALOCET · NEXICLON XR · NUCALA · NUEDEXTA · Natesto · OFEV · OPSUMIT · ORLADEYO · Odactra · Omnia · OneTouch · Ozempic · PRALUENT · PURIFIED CORTROPHIN GEL · ProAir Digihaler · QULIPTA · QVAR · RELISTOR · RELTONE 200 MG · RYBELSUS · Repatha · Respiratoriy Care Undiv · Rybelsus · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPEEDICATH · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TYVASO · Tresiba · UBRELVY · UTIBRON NEOHALER · VALTOCO · VERQUVO · VIBERZI · VRAYLAR · Vascepa · Victoza · WATCHMAN · Wakix · Wellcentive Undiv · XARELTO · XIFAXAN · XYWAV · Xenleta · Xofluza · Xolair · Yupelri · ZENPEP · ZYPITAMAG · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in NJ.
Geographic Context
Pulmonary diseases within 10 mi
652
Per 100K population
91.8
County median income
$90,032
Nearest hospital
CAREPOINT HEALTH-CHRIST HOSPITAL
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Elamir is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NJ), with speaking/promotional industry engagement in the top 2% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Elamir experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Elamir performed 1,161 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Elamir receive payments from pharmaceutical companies?
Yes. Dr. Elamir received a total of $117,086 from 77 companies across 723 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Elamir's costs compare to other pulmonary diseases in Jersey City?
Dr. Elamir's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Elamir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Jersey City
Browse pulmonary diseases in Jersey City ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology